Sulforaphane, an isothiocyanate of plant origin, has shown its therapeutic properties in experimental models of retinal degeneration by activating NRF2, resulting in increased levels of TXN, TXNRD, and heme oxygenase-1 (HO-1) [42,198]. Here, TXN is linked to retinal degeneration.